Renal sympathetic denervation as antihypertensive therapy--a reappraisal of first results.
Renal sympathetic denervation (RSD) has previously been discussed in this journal. Since then, it has become a common procedure in many countries to use RSD to treat patients with putatively resistant hypertension. In Germany alone, RSD is now routinely used to treat resistant hypertension at the expense of the health-care system. The Germans have established a national registry to systematically and continuously follow up hypertensive patients who have undergone RSD. However, there are concerns because the registry is voluntary and physicians practicing the procedure may not have the accrual of new knowledge regarding the utility of RSD as their primary professional aim. Since the previous editorial on renal denervation, new results have been published. Therefore, it is appropriate to re-evaluate RSD.
Medizinische Klinik 4 (Nephrologie und Hypertensiologie), Friedrich Alexander Universitaet Erlangen-Nuernberg, Erlangen-Nuremberg, Germany.
Roland
R
Veelken
Johannes F E
JF
Mann
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000601:surgery*; D007668:Kidney / Q000294:innervation* / Q000473:pathology / Q000601:surgery*; D013562:Sympathectomy / Q000379:methods*
D000959:Antihypertensive Agents
antihypertensive therapy; arterial hypertension; renal sympathetic denervation